Dow Up0.00% Nasdaq Up0.09%

More On TH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Theratechnologies Inc. (TH.TO)

-Toronto
0.37 Down 0.01(2.63%) Nov 28, 3:56PM EST
ProfileGet Profile for:
Theratechnologies Inc.
2310 Alfred-Nobel Boulevard
Montr, QC H4S 2B4
Canada - Map
Phone: 514-336-7800
Fax: 514-331-9691
Website: http://www.theratech.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

Business Summary 

Theratechnologies Inc., a biopharmaceutical company, develops and commercializes therapeutic peptide products. The company’s lead product is EGRIFTA (tesamorelin for injection), an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in the United States. It also focuses on commercializing EGRIFTA in Latin America, Africa, the Middle East, Europe, Russia, South Korea, Taiwan, Thailand, and certain central Asian countries. Theratechnologies Inc. also has TH1173, a second-generation GRF peptide that has completed preclinical studies in its product pipeline. The company was founded in 1993 and is headquartered in Montréal, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Theratechnologies Inc.

Key Executives 
 PayExercised
Mr. Luc Tanguay M.Sc., C.F.A., 56
Chief Exec. Officer, Pres and Non-Independent Director
N/AN/A
Ms. Marie-No Colussi C.A., 45
VP of Fin.
N/AN/A
Mr. Christian Marsolais Ph.D., 51
Sr. VP of Scientific Affairs and Alliances
N/AN/A
Mr. Jocelyn Lafond LL.B., L.L.M., 46
VP of Legal Affairs and Sec.
N/AN/A
Mr. Pierre Perazzelli B.Sc. , 62
VP of Pharmaceutical Devel.
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.